LASV inhibitor 3.3

CAS No. 554438-52-7

LASV inhibitor 3.3( LAMP1 inhibitor 3.3 )

Catalog No. M15014 CAS No. 554438-52-7

LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 61 In Stock
2MG 29 In Stock
5MG 49 In Stock
10MG 82 In Stock
25MG 167 In Stock
50MG 270 In Stock
100MG 387 In Stock
200MG 541 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LASV inhibitor 3.3
  • Note
    Research use only, not for human use.
  • Brief Description
    LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).
  • Description
    LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM), inhibits LASV GP-mediated infection and cross-links to the LASV receptor, LAMP1, in cells; does not inhibits the GP-mediated infection of LCMV, LuJo virus (LUJV) or Junin virus (JUNV), Ebola virus (EBOV) or vesicular stomatitis virus (VSV); inhibits LAMP1 binding to LASV GP, which is cholesterol-dependent and sensitive to 3.3 inhibition; LASV inhibitor 3.3 is a competitive inhibitor of cholesterol binding to LAMP1.
  • In Vitro
    Western Blot Analysis Cell Line:293T LAMP1 KO cells expressing LASV GP-His and 293T pX459 cells Concentration:1 and 10 μM Incubation Time:1 hour Result:Inhibited the LASV GP binds to LAMP1.
  • In Vivo
    ——
  • Synonyms
    LAMP1 inhibitor 3.3
  • Pathway
    Microbiology/Virology
  • Target
    Arenavirus
  • Recptor
    Arenavirus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    554438-52-7
  • Formula Weight
    471.645
  • Molecular Formula
    C30H37N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (53.01 mM)
  • SMILES
    C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CNC(=O)C45CC6CC(C4)CC(C6)C5
  • Chemical Name
    N-(2-(4-benzhydrylpiperazin-1-yl)-2-oxoethyl)adamantane-1-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang MK, et al. PLoS Pathog. 2018 Sep 28;14(9):e1007322. 2. PCT Int. Appl. (2013), WO 2013022550 A2 20130214.
molnova catalog
related products
  • LCMV gp33-41

    LCMV gp33-41, the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41.

  • Nucleoprotein 396-40...

    Nucleoprotein (396-404) is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen.

  • LHF-535

    LHF-535 (LHF535, LHF 535) is a small-molecule viral entry inhibitor that targets the arenavirus envelope glycoprotein, exhibits potent antiviral activity against a broad array of hemorrhagic fever arenaviruses with IC50 of 0.1-0.3 nM.